Skip to content
The Policy VaultThe Policy Vault

Tryptyr (acoltremon ophthalmic solution)Medica

Dry eye disease

Initial criteria

  • Patient has a diagnosis of dry eye disease (examples include dry eye syndrome or keratoconjunctivitis sicca)
  • age ≥ 18 years
  • NOT used concomitantly with an ophthalmic cyclosporine product (Cequa, Restasis/generic, or Vevye), Tyrvaya (varenicline nasal solution), or Xiidra (lifitegrast 5% ophthalmic solution)

Approval duration

1 year